Pharmacological inhibition of MERTK induces in vivo retinal degeneration: a multimodal imaging ocular safety assessment
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 96 (2) , 613-624
Abstract
The receptor tyrosine kinase, MERTK, plays an essential role in homeostasis of the retina via efferocytosis of shed outer nuclear segments of photoreceptors. The Royal College of Surgeons rat model of retinal degeneration has been linked to loss-of-function of MERTK, and together with the MERTK knock-out mouse, phenocopy retinitis pigmentosa in humans with MERTK mutations. Given recent efforts and interest in MERTK as a potential immuno-oncology target, development of a strategy to assess ocular safety at an early pre-clinical stage is critical. We have applied a state-of-the-art, multi-modal imaging platform to assess the in vivo effects of pharmacological inhibition of MERTK in mice. This involved the application of mass spectrometry imaging (MSI) to characterize the ocular spatial distribution of our highly selective MERTK inhibitor; AZ14145845, together with histopathology and transmission electron microscopy to characterize pathological and ultra-structural change in response to MERTK inhibition. In addition, we assessed the utility of a human retinal in vitro cell model to identify perturbation of phagocytosis post MERTK inhibition. We identified high localized total compound concentrations in the retinal pigment epithelium (RPE) and retinal lesions following 28 days of treatment with AZ14145845. These lesions were present in 4 of 8 treated animals, and were characterized by a thinning of the outer nuclear layer, loss of photoreceptors (PR) and accumulation of photoreceptor outer segments at the interface of the RPE and PRs. Furthermore, the lesions were very similar to that shown in the RCS rat and MERTK knock-out mouse, suggesting a MERTK-induced mechanism of PR cell death. This was further supported by the observation of reduced phagocytosis in the human retinal cell model following treatment with AZ14145845. Our study provides a viable, translational strategy to investigate the pre-clinical toxicity of MERTK inhibitors but is equally transferrable to novel chemotypes.Keywords
This publication has 39 references indexed in Scilit:
- Assessing a Novel Depot Delivery Strategy for Noninvasive Administration of VEGF/PDGF RTK Inhibitors for Ocular Neovascular DiseaseInvestigative Ophthalmology & Visual Science, 2013
- A New Safety Concern for Glaucoma Treatment Demonstrated by Mass Spectrometry Imaging of Benzalkonium Chloride Distribution in the Eye, an Experimental Study in RabbitsPLOS ONE, 2012
- Ocular toxicity from systemically administered xenobioticsExpert Opinion on Drug Metabolism & Toxicology, 2012
- Defective photoreceptor phagocytosis in a mouse model of enhanced S‐cone syndrome causes progressive retinal degenerationThe FASEB Journal, 2011
- Distribution of chloroquine in ocular tissue of pigmented rat using matrix‐assisted laser desorption/ionization imaging quadrupole time‐of‐flight tandem mass spectrometryRapid Communications in Mass Spectrometry, 2011
- Spatial Segmentation of Imaging Mass Spectrometry Data with Edge-Preserving Image Denoising and ClusteringJournal of Proteome Research, 2010
- MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histologyHistochemistry and Cell Biology, 2008
- The Biosynthesis of A2E, a Fluorophore of Aging Retina, Involves the Formation of the Precursor, A2-PE, in the Photoreceptor Outer Segment MembraneJournal of Biological Chemistry, 2000
- Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS ratHuman Molecular Genetics, 2000
- Binding of Drugs to Eye Melanin Is Not Predictive of Ocular ToxicityRegulatory Toxicology and Pharmacology, 1998